Travere Therapeutics
TVTX
TVTX
130 hedge funds and large institutions have $516M invested in Travere Therapeutics in 2019 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
29% less call options, than puts
Call options by funds: $6.19M | Put options by funds: $8.72M
41% less capital invested
Capital invested by funds: $874M → $516M (-$358M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
130
Holding in Top 10
–
Calls
$6.19M
Puts
$8.72M
Top Buyers
| 1 | +$46.2M | |
| 2 | +$8.54M | |
| 3 | +$6.2M | |
| 4 |
Renaissance Technologies
New York
|
+$4.81M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$2.95M |
Top Sellers
| 1 | -$17.4M | |
| 2 | -$12.3M | |
| 3 | -$12.3M | |
| 4 |
SCM
Scopia Capital Management
New York
|
-$7.71M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.99M |